Detalhe da pesquisa
1.
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 16(8)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672547